CytoSorbents to Present at the 8th Annual Dawson James Conference - CytoSorbents (NASDAQ:CTSO)

PRINCETON, N.J., Oct. 05, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ:CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood

Related Keywords

Canada ,United States ,Phillip Chan ,Cytosorbents Corporation ,Dawson James ,Us Department Of Health ,Material Command ,Us Army ,National Institutes Of Health ,National Heart ,Human Services ,Blood Institute ,Health Canada ,European Union ,Us Air ,Chief Executive Officer ,Dawson James Small Cap Growth ,Wyndham Grand Jupiter ,Harbourside Place ,Sorbents Corporation ,Use Authorization ,Timely Antithrombotic Removal ,Device Designations ,National Institutes ,Operations Command ,Air Force Material Command ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,